BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 18071319)

  • 41. Requirement of the MEK5-ERK5 pathway for neural differentiation in Xenopus embryonic development.
    Nishimoto S; Kusakabe M; Nishida E
    EMBO Rep; 2005 Nov; 6(11):1064-9. PubMed ID: 16179948
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MEK5/ERK5 signaling inhibition increases colon cancer cell sensitivity to 5-fluorouracil through a p53-dependent mechanism.
    Pereira DM; Simões AE; Gomes SE; Castro RE; Carvalho T; Rodrigues CM; Borralho PM
    Oncotarget; 2016 Jun; 7(23):34322-40. PubMed ID: 27144434
    [TBL] [Abstract][Full Text] [Related]  

  • 43. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 44. ERK5 and ERK2 cooperate to regulate NF-kappaB and cell transformation.
    Pearson G; English JM; White MA; Cobb MH
    J Biol Chem; 2001 Mar; 276(11):7927-31. PubMed ID: 11118448
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A novel role for extracellular signal-regulated kinase 5 and myocyte enhancer factor 2 in medulloblastoma cell death.
    Sturla LM; Cowan CW; Guenther L; Castellino RC; Kim JY; Pomeroy SL
    Cancer Res; 2005 Jul; 65(13):5683-9. PubMed ID: 15994942
    [TBL] [Abstract][Full Text] [Related]  

  • 46. ERK1/2-driven and MKP-mediated inhibition of EGF-induced ERK5 signaling in human proximal tubular cells.
    Sarközi R; Miller B; Pollack V; Feifel E; Mayer G; Sorokin A; Schramek H
    J Cell Physiol; 2007 Apr; 211(1):88-100. PubMed ID: 17131384
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Glucose-induced endothelin-1 expression is regulated by ERK5 in the endothelial cells and retina of diabetic rats.
    Wu Y; Feng B; Chen S; Zuo Y; Chakrabarti S
    Can J Physiol Pharmacol; 2010 Jun; 88(6):607-15. PubMed ID: 20628425
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Regulation of nuclear translocation of extracellular signal-regulated kinase 5 by active nuclear import and export mechanisms.
    Kondoh K; Terasawa K; Morimoto H; Nishida E
    Mol Cell Biol; 2006 Mar; 26(5):1679-90. PubMed ID: 16478989
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ghrelin and a novel preproghrelin isoform are highly expressed in prostate cancer and ghrelin activates mitogen-activated protein kinase in prostate cancer.
    Yeh AH; Jeffery PL; Duncan RP; Herington AC; Chopin LK
    Clin Cancer Res; 2005 Dec; 11(23):8295-303. PubMed ID: 16322288
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regulation of c-Fos and Fra-1 by the MEK5-ERK5 pathway.
    Terasawa K; Okazaki K; Nishida E
    Genes Cells; 2003 Mar; 8(3):263-73. PubMed ID: 12622723
    [TBL] [Abstract][Full Text] [Related]  

  • 51. ERK5 and Cell Proliferation: Nuclear Localization Is What Matters.
    Gomez N; Erazo T; Lizcano JM
    Front Cell Dev Biol; 2016; 4():105. PubMed ID: 27713878
    [TBL] [Abstract][Full Text] [Related]  

  • 52. ERK5 is activated by oncogenic BRAF and promotes melanoma growth.
    Tusa I; Gagliardi S; Tubita A; Pandolfi S; Urso C; Borgognoni L; Wang J; Deng X; Gray NS; Stecca B; Rovida E
    Oncogene; 2018 May; 37(19):2601-2614. PubMed ID: 29483645
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Non-redundant function of the MEK5-ERK5 pathway in thymocyte apoptosis.
    Sohn SJ; Lewis GM; Winoto A
    EMBO J; 2008 Jul; 27(13):1896-906. PubMed ID: 18548009
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Heat shock protein expression independently predicts clinical outcome in prostate cancer.
    Cornford PA; Dodson AR; Parsons KF; Desmond AD; Woolfenden A; Fordham M; Neoptolemos JP; Ke Y; Foster CS
    Cancer Res; 2000 Dec; 60(24):7099-105. PubMed ID: 11156417
    [TBL] [Abstract][Full Text] [Related]  

  • 55. SUMOylation Is Required for ERK5 Nuclear Translocation and ERK5-Mediated Cancer Cell Proliferation.
    Erazo T; Espinosa-Gil S; Diéguez-Martínez N; Gómez N; Lizcano JM
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32209980
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HB-EGF induces cardiomyocyte hypertrophy via an ERK5-MEF2A-COX2 signaling pathway.
    Lee KS; Park JH; Lim HJ; Park HY
    Cell Signal; 2011 Jul; 23(7):1100-9. PubMed ID: 21244855
    [TBL] [Abstract][Full Text] [Related]  

  • 57. BAY-885, a mitogen-activated protein kinase kinase 5 inhibitor, induces apoptosis by regulating the endoplasmic reticulum stress/Mcl-1/Bim pathway in breast cancer cells.
    Wang L; Ji X; Mao C; Yu R
    Bioengineered; 2022 May; 13(5):12888-12898. PubMed ID: 35609325
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Extracellular signal regulated kinase 5 (ERK5) is required for the differentiation of muscle cells.
    Dinev D; Jordan BW; Neufeld B; Lee JD; Lindemann D; Rapp UR; Ludwig S
    EMBO Rep; 2001 Sep; 2(9):829-34. PubMed ID: 11520859
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Focal adhesion kinase controls aggressive phenotype of androgen-independent prostate cancer.
    Johnson TR; Khandrika L; Kumar B; Venezia S; Koul S; Chandhoke R; Maroni P; Donohue R; Meacham RB; Koul HK
    Mol Cancer Res; 2008 Oct; 6(10):1639-48. PubMed ID: 18922979
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation.
    Ghosh PM; Malik SN; Bedolla RG; Wang Y; Mikhailova M; Prihoda TJ; Troyer DA; Kreisberg JI
    Endocr Relat Cancer; 2005 Mar; 12(1):119-34. PubMed ID: 15788644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.